Literature DB >> 15826896

Polio immunization policy in Mexico: economic assessment of current practice and future alternatives.

A Mascareñas1, J Salinas, A Tasset-Tisseau, C Mascareñas, M M Khan.   

Abstract

The World Health Organization recommends that all children aged less than 5 years should be vaccinated against polio through intensive immunization programmes as well as routine immunization. A national immunization week (NIW) was held in February 2002 in the Monterrey district of Mexico. A prospective micro-costing study was conducted to measure the total cost to the state of the NIW, the cost profile, and the ratio of cost per immunization contact to cost per dose of oral polio vaccine (OPV), and to compare OPV and inactive polio vaccine (IPV) in economic terms. Two scenarios were used as the basis for calculation. The cost of volunteers was excluded from the "lower-cost scenario" and included in the "upper-cost scenario". The total cost of the NIW was USD 100,454 for the lower-cost scenario and USD 156,614 for the upper-cost scenario. The major part of the costs was personnel costs (67.30 and 77.53% of the total costs in the lower- and upper-cost scenario, respectively). The ratio of cost per immunization contact to cost per dose of OPV was 6.45 for the lower-cost scenario and 10.05 for the upper-cost scenario. Changing from the current OPV-based intensive and routine schedule to a sequential IPV-OPV routine schedule would save USD 14.52 per vaccinated child, and changing to a full IPV routine schedule would save USD 9.41 per vaccinated child.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15826896     DOI: 10.1016/j.puhe.2004.08.020

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  4 in total

1.  Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.

Authors:  Agustín Ciapponi; Ariel Bardach; Lucila Rey Ares; Demián Glujovsky; María Luisa Cafferata; Silvana Cesaroni; Aikant Bhatti
Journal:  Cochrane Database Syst Rev       Date:  2019-12-05

2.  Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029.

Authors:  Dominika A Kalkowska; Kimberly M Thompson
Journal:  Risk Anal       Date:  2021-02       Impact factor: 4.000

3.  Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine.

Authors:  Ignacio Olivera; Carlos Grau; Hugo Dibarboure; Juan Pablo Torres; Gustavo Mieres; Luis Lazarov; Fabián P Alvarez; Juan Guillermo López Yescas
Journal:  BMC Health Serv Res       Date:  2020-04-09       Impact factor: 2.655

Review 4.  Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication.

Authors:  Kimberly M Thompson; Dominika A Kalkowska
Journal:  Expert Rev Vaccines       Date:  2020-08-01       Impact factor: 5.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.